Metraipolis › archive › dc_864011df413b
Using real-world data to predict findings of an ongoing phase IV trial: glycemic control of semaglutide versus standard of care — Europe PMC PMID:41161770
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41161770
- DOI
- 10.1136/bmjdrc-2025-005180
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T23:40:25.936Z
- SHA-256 of the archived text
b8fadcc9f30dc858363761d1e1945e6e522e7214dff01ff21db7e58bada50a4d- Stable URL of this page
https://metraipolis.com/documento/dc_864011df413b
How to cite
Using real-world data to predict findings of an ongoing phase IV trial: glycemic control of semaglutide versus standard of care — Europe PMC PMID:41161770 — Europe PMC (en), https://europepmc.org/article/MED/41161770 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_864011df413b (Metraipolis archive dc_864011df413b, sha256 b8fadcc9f30dc858363761d1e1945e6e522e7214dff01ff21db7e58bada50a4d)
BibTeX
@misc{dc864011df413b,
title = {Using real-world data to predict findings of an ongoing phase IV trial: glycemic control of semaglutide versus standard of care — Europe PMC PMID:41161770},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41161770},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_864011df413b; sha256 b8fadcc9f30dc858363761d1e1945e6e522e7214dff01ff21db7e58bada50a4d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41161770. Agents can read the archived copy with the MCP tool read_document.